Provided by Tiger Trade Technology Pte. Ltd.

Creative Medical Technology Holdings, Inc.

0.8709
+0.04895.95%
Volume:145.07K
Turnover:125.20K
Market Cap:5.74M
PE:-0.45
High:0.8967
Open:0.8600
Low:0.8289
Close:0.8220
52wk High:6.25
52wk Low:0.6200
Shares:6.59M
Float Shares:6.33M
Volume Ratio:1.00
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9543
EPS(LYR):-2.5200
ROE:-77.88%
ROA:-47.32%
PB:0.66
PE(LYR):-0.35

Loading ...

Creative Medical Files New US Provisional Patent to Expand Ultrasome Cell-Free Platform Protection

Reuters
·
Yesterday

Creative Medical Technology - Files New U.S. Provisional Patent Application

THOMSON REUTERS
·
Yesterday

Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing

GlobeNewswire
·
Yesterday

Creative Medical Technology Holdings Stockholders Approved Increase in Authorized Common Shares to 100 Million

Reuters
·
Sep 01

Roth believes Creative Medical’s ADAPT trial in CLBO ‘likely to succeed’

TIPRANKS
·
Aug 21

Creative Medical Completes Enrollment, Treatment in FDA-Cleared ADAPT Trial of Olastrocel for Chronic Lower Back Pain

Reuters
·
Aug 20

Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation and Phase 3 Planning

THOMSON REUTERS
·
Aug 20

Creative Medical Technology Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 08

Creative Medical Net Loss Widens 22.5% to $1.51 Million in Q2 2026

Reuters
·
Aug 08

NASDAQ Trade Halt Volatility Trading Pause at 10:50 Am

Reuters
·
Aug 06

Creative Medical receives notice of allowance for new U.S. patent

TIPRANKS
·
Aug 06

Creative Medical Technology - Patent to Extend Ip Protection for Myelocelz Platform in Type 1 Diabetes

THOMSON REUTERS
·
Aug 06

Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms

GlobeNewswire
·
Aug 06

Top Premarket Gainers

MT Newswires Live
·
Aug 06

Creative Medical Technology Holdings Inc Expected to Post a Loss of 39 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Creative Medical Technology Holdings Issues Mid-year Update

THOMSON REUTERS
·
Jul 01

Creative Medical Technology Holdings Issues Mid-Year Update

GlobeNewswire
·
Jul 01

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds

THOMSON REUTERS
·
Jul 01

Top Premarket Decliners

MT Newswires Live
·
Jun 26

Creative Medical Files for Securities Offering

MT Newswires Live
·
Jun 26